Madrigal Pharmaceuticals
Trade Madrigal Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MDGL
Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia.
MDGL Key Statistics
Stock Snapshot
As of today, Madrigal Pharmaceuticals(MDGL) shares are valued at $441.34. The company's market cap stands at 10.12B, with a P/E ratio of -34.45.
On 2026-03-18, Madrigal Pharmaceuticals(MDGL) stock traded between a low of $427.76 and a high of $444.90. Shares are currently priced at $441.34, which is +3.2% above the low and -0.8% below the high.
The Madrigal Pharmaceuticals(MDGL)'s current trading volume is 162.84K, compared to an average daily volume of 290.43K.
In the last year, Madrigal Pharmaceuticals(MDGL) shares hit a 52-week high of $615.00 and a 52-week low of $265.00.
In the last year, Madrigal Pharmaceuticals(MDGL) shares hit a 52-week high of $615.00 and a 52-week low of $265.00.
MDGL News
Madrigal Pharmaceuticals recently reported that its MASH drug Rezdiffra generated nearly US$1.00 billion in its first full year on the market, reinforcing the c...
Analyst ratings
88%
of 17 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.